FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / DELIVERY ORDER

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDE

Awarded to GLAXOSMITHKLINE, LLC

PIID 75A50122F61004US · USAspendingBiotechnology & Pharmaceuticals
$22.9M
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$22,877,697sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateSep 14, 2022
Company legal name
GLAXOSMITHKLINE, LLC
UEI / CAGE
FRHTPHMZMX47 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
Office of Assistant Secretary for Preparedness and Response
Industry
Biotechnology & Pharmaceuticals
NAICS
541714
PSC
AN12
Performance period
Not reported — Not reported
Recipient address
5 MOORE DR RESEARCH TRIANGLE PK, DURHAM, DURHAM, NC, 27709
Place of performance
DURHAM, DURHAM, NC, 27709
Source last modified
Nov 3, 2026

Description

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD.

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Contract modified

    THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: TO UPDATE ARTICLE H.3. HHSAR 352.237-75 KEY PERSONNEL (DECEMBER 2015) FOR STUDY DELIVERY LEAD FOR TO 75A50122F61004, CLIN 0013. SER

    US · usaspendingSource ↗
  2. Contract modified

    THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: 1. TO TRANSFER 65K H5N8 VIALS FROM TASK ORDER 75A50122F61004 ( CLIN 0007C) TO TASK ORDER 75A50123F61006.

    US · usaspendingSource ↗
  3. Contract modified

    THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: INCREASE FUNDING FOR TASK ORDER F61004 FROM $19,336,207 BY $3,541,490 TO $22,877,697. (SEE CONTINUATION PAGE) 1. UPDATE THE EX

    US · usaspendingSource ↗
  4. Value increased

    THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: INCREASE FUNDING FOR TASK ORDER F61004 FROM $19,336,207 BY $3,541,490 TO $22,877,697. (SEE CONTINUATION PAGE) 1. UPDATE THE EX

    US · usaspending$3.5MSource ↗
  5. Contract modified

    THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDE

    US · usaspendingSource ↗
  6. Award announced

    THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDE

    US · usaspendingSource ↗
  7. Value increased

    THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDE

    US · usaspending$19.3MSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Sep 21, 2023P00004MNot reportedNot reportedNot reportedTHE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: TO UPDATE ARTICLE H.3. HHSAR 352.237-75 KEY PERSONNEL (DECEMBER 2015) FOR STUDY DELIVERY LEAD FOR TO 75A50122F61004, CLIN 0013. SERGE BEUDJEKIAN WILL REPLACE GEETHA BHAT AS STUDY DELIVERY LEAD.USAspending ↗
Aug 31, 2023P00003MNot reportedNot reportedNot reportedTHE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: 1. TO TRANSFER 65K H5N8 VIALS FROM TASK ORDER 75A50122F61004 ( CLIN 0007C) TO TASK ORDER 75A50123F61006.USAspending ↗
May 16, 2023P00002M$3,541,490.00Not reportedNot reportedTHE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: INCREASE FUNDING FOR TASK ORDER F61004 FROM $19,336,207 BY $3,541,490 TO $22,877,697. (SEE CONTINUATION PAGE) 1. UPDATE THE EXISTING SOW FOR CLIN 0013 INCLUDED AS ATTACHMENT 1A. 2. REVUSAspending ↗
Oct 13, 2022P00001BNot reportedNot reportedNot reportedTHE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD.USAspending ↗
Sep 14, 20220Not reported$19,336,207.00Not reportedNot reportedTHE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD.USAspending ↗